RxDoctor Payments Data

Brian Kauth, MD

Family Medicine · Hickory, NCNPI 1780797803

Payments from drug & device makers

$1,001in general payments, 2019–2025

Across 63 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$155
  • Johnson & Johnson$129
  • GSK$117
  • Gilead$93
  • Pfizer$90
  • Supernus Pharmaceuticals, Inc.$88
  • plus $329 from 14 others

What the payments were for

  • Food & beverage$1,001100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,001 in reported general payments places this provider in the 65th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$430
Medicare patients
13
Services billed
22

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban115$121,684
RybelsusSemaglutide36$46,300
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$34,808
JanuviaSitagliptin Phosphate33$34,364
OzempicSemaglutide31$29,839
TrulicityDulaglutide24$28,686
XareltoRivaroxaban26$24,562
Soliqua 100-33Insulin Glargine/Lixisenatide19$16,960
FarxigaDapagliflozin Propanediol16$12,496
TradjentaLinagliptin11$10,982
MyrbetriqMirabegron21$10,769
Tresiba Flextouch U-100Insulin Degludec20$9,853
SymbicortBudesonide/Formoterol Fumarate34$9,742
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,998
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate32$8,027

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$90$121,684115 claims
Novo NordiskRybelsus, Ozempic$66$76,13867 claims
GSKTrelegy Ellipta, Breo Ellipta$117$41,76259 claims
MerckJanuvia$11$34,36433 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$13$31,23664 claims
Lilly USA, LLCTrulicity$15$28,68624 claims
Johnson & JohnsonXarelto$129$24,56226 claims
Astellas Pharma US IncMyrbetriq$11$10,76921 claims
AbbVieSynthroid$155$1,11815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Hickory

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →